![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABC of antithrombotic therapy
Gregory Lip and Andrew Blann, editors. Published by BMJ
Books.
ISBN 0-7279-17714. Contains 67pages. Price GBP16.95 This short text delivers informative reviews on thrombotic
issues pertaining to a diverse range of medical and surgical specialties. The
book’s concise style, typical of the ABC series in the British Medical
Journal, offers a mix of relevant research and clinical data, focusing on
patient management. Included are useful references to North American and British
antithrombotic guidelines, and each chapter provides a "further reading" list
for enthusiastic readers. The text is mainly written by staff at the
Haemostasis, Thrombosis and Vascular Biology Unit at the University Department
of Medicine, City Hospital, Birmingham.
Chapters 1 and 2 offer useful overviews of antithrombotic
drugs and bleeding risk; covering antiplatelet agents, anticoagulants and
thrombolytics. There are clear tables, bullet point fact lists, and explanatory
diagrams. Safety criteria for prescribing these drugs are reviewed.
The chapter on diagnosis and prevention of venous
thromboembolism covers the important principles of pre-test probability
assessment for DVT and clinical probability criteria for PE. Prevention
strategies are classified according to risk assessment. A very good
evidence-based guide on thromboprophylactic strategies is presented for various
risk settings and for various anticoagulant products, adapted from ACCP
guidelines.
The chapter on atrial fibrillation tackles the challenge of
‘who to treat’, based on risk stratification schemes. The cardiology
section covers anticoagulation guidelines for cardioversion and acute coronary
syndromes. Sub-specialised areas of thrombosis in pregnancy, and in the
paediatric setting, are covered conservatively—while not forgetting to
address useful recent developments, such as appropriate strategies for managing
LMWHs, the anti-phospholipid syndrome, and prosthetic cardiac valve
thromboprophylaxis during pregnancy. Finally, the perennial issue of chronic
oral anticoagulant management is reviewed for the UK setting, which is equally
applicable to the New Zealand environment.
That such a diverse range of topics is covered in a 67-page
text underscores its concise layout. I would recommend this book to generalists
seeking an update, and to students as a concise learning tool covering
antithrombotic interventions across a spectrum of clinical settings.
Mark Smith
Consultant Haematologist Canterbury Health Laboratories Christchurch |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |